André Giroux
Boehringer Ingelheim
3 Papers
6 Citations
André Giroux is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Congenital cytomegalovirus infection & Polymerase. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Patent
Naphthyridinone derivatives as inhibitors of cytomegalovirus dna polymerase
Olivier Lepage,Murray D. Bailey,Pierre L. Beaulieu,François Bilodeau,Rebekah J. Carson,André Giroux,Cédrickx Godbout,Benoît Moreau,Julie Naud,Mathieu Parisien,Martin Poirier,Maude Poirier,Simon Surprenant,Carl Thibeault,Lee Fader +14 more
- 03 Apr 2013
TL;DR: In this article, the authors defined a set of compounds of Formula (I) for the treatment of cytomegalovirus disease and/or infection, where n, m, R 1, R 2, R 3, R 4, R 5 and R 6 are defined.
4
Patent
Cytomegalovirus inhibitor compounds
Lee Fader,Olivier Lepage,Murray D. Bailey,Pierre L. Beaulieu,François Bilodeau,Rebekah J. Carson,André Giroux,Cédrickx Godbout,Benoît Moreau,Julie Naud,Mathieu Parisien,Martin Poirier,Maude Poirier,Simon Surprenant,Carl Thibeault +14 more
- 03 Apr 2013
TL;DR: In this paper, the authors defined a set of compounds of Formula (I) for the treatment of cytomegalovirus disease and/or infection, where n, m, R1, R2, R3, R4, R5 and R6 are defined.
2
Patent
1,8-naphthyridin-2(1h)-one derivatives as cytomegalovirus inhibitors
Lee Fader,Pierre L. Beaulieu,Murray D. Bailey,François Bilodeau,Rebekah J. Carson,André Giroux,Cédrickx Godbout,Oliver Hucke,Marc-André Joly,Mélissa Leblanc,Olivier Lepage,Benoît Moreau,Julie Naud,Martin Poirier,Elisia Villemure +14 more
- 03 Apr 2013
TL;DR: In this article, the Compounds of Formula (I) were defined for the treatment of cytomegalovirus disease and/or infection, wherein n, A, R1, R2, R3 and R5 were used.